These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 28877395)

  • 21. Improving clinical outcomes for women with overactive bladder or urinary retention symptoms: a comparison of motor response voltages (1-9 V) during Stage 1 sacral neuromodulation.
    Marinkovic SP; Ford JC
    BJU Int; 2018 Sep; 122(3):472-479. PubMed ID: 29637712
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sacral neuromodulation outcomes in male patients with chronic urinary retention.
    Saber-Khalaf M; Abtahi B; Gonzales G; Helal M; Elneil S
    Neuromodulation; 2015 Jun; 18(4):329-34; discussion 334. PubMed ID: 25655708
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sacral neuromodulation in patients with idiopathic overactive bladder after initial botulinum toxin therapy.
    Smits MA; Oerlemans D; Marcelissen TA; Van Kerrebroeck PE; De Wachter SG
    J Urol; 2013 Dec; 190(6):2148-52. PubMed ID: 23872028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Remotely programmed sacral neuromodulation for the treatment of patients with refractory overactive bladder: a prospective randomized controlled trial evaluating the safety and efficacy of a novel sacral neuromodulation device.
    Zhang Y; Zhang P; Tian X; Chen G; Li Y; Zhang Y; Xu Z; Wei Z; Zhang W; Ma L; Shi B; Liao L; Wang J
    World J Urol; 2019 Nov; 37(11):2481-2492. PubMed ID: 30809700
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Impact of Duration of Complaints on Successful Outcome of Sacral Neuromodulation.
    Jairam R; Drossaerts J; van Koeveringe G; van Kerrebroeck P
    Urol Int; 2017; 99(1):51-55. PubMed ID: 28478446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study.
    Jairam R; Drossaerts J; Vrijens D; Leue C; van Kerrebroeck P; van Koeveringe G
    Neurourol Urodyn; 2018 Jun; 37(5):1801-1808. PubMed ID: 29504634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sacral neuromodulation for refractory overactive bladder after prior intravesical onabotulinumtoxinA treatment.
    Hoag N; Plagakis S; Pillay S; Edwards AW; Gani J
    Neurourol Urodyn; 2017 Jun; 36(5):1377-1381. PubMed ID: 27612039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Supervised 3 Weeks Test Phase in Sacral Neuromodulation with a 1-Year Followup.
    Tilborghs S; Van de Borne S; Vaganée D; De Win G; De Wachter S
    J Urol; 2021 Jan; 205(1):206-212. PubMed ID: 32716692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of neuromodulation in patients with neurogenic overactive bladder.
    Lay AH; Das AK
    Curr Urol Rep; 2012 Oct; 13(5):343-7. PubMed ID: 22865208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sacral Neuromodulation: Determining Predictors of Success.
    Morgan TN; Pace N; Mohapatra A; Ren D; Kunkel G; Tennyson L; Shepherd JP; Chermansky CJ
    Urology; 2021 Jul; 153():124-128. PubMed ID: 32619594
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Migration of a sacral neuromodulation electrode after vaginal delivery in a female patient with non-obstructive urinary retention.
    El-Akri M; Peyronnet B
    Fr J Urol; 2024 Jun; 34(6):102605. PubMed ID: 38431080
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preliminary analysis of stimulation parameters for sacral neuromodulation in different indications: a multicenter retrospective cohort study from China.
    Meng L; Yan Z; Wang X; Zhang Y; Zhu Z; Zhu W; Ling Q; Sun X; Gu Y; Lv J; Li Y
    Int J Surg; 2024 Jun; 110(6):3536-3542. PubMed ID: 38445489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Functional Outcomes of S3 Sacral Neuromodulation for the Treatment of Idiopathic Overactive Bladder.
    Ismail S; Chartier-Kastler E; Perrouin-Verbe MA; Rose-Dite-Modestine J; Denys P; Phé V
    Neuromodulation; 2017 Dec; 20(8):825-829. PubMed ID: 28967986
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Results of Sacral Neuromodulation Therapy for Urinary Voiding Dysfunction: Five-Year Experience of a Retrospective, Multicenter Study in China.
    Zhang P; Wang JY; Zhang Y; Liao L; Lv JW; Ling Q; Wei ZQ; Zhong T; Xu ZH; Wen W; Li JY; Luo DY
    Neuromodulation; 2019 Aug; 22(6):730-737. PubMed ID: 30609180
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive impairment does not impact sacral neuromodulation implant rates for overactive bladder.
    Zillioux J; Lewis KC; Hettel D; Goldman HB; Vasavada SP; Gill BC
    Neurourol Urodyn; 2023 Mar; 42(3):623-630. PubMed ID: 36701189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patients with Sacral Neuromodulation: What Are the Factors Affecting Their Therapy Satisfaction?
    Banakhar M; Hassouna M
    Urol Int; 2019; 103(4):450-453. PubMed ID: 31574517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of sacral neuromodulation: a treatment for patients with symptoms of lower urinary tract dysfunction.
    Fletcher N
    Br J Nurs; 2020 Aug; 29(15):848-856. PubMed ID: 32790556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy of sacral neuromodulation on urological diseases: a multicentric research project.
    Cardarelli S; D'Elia C; Cerruto MA; Curti P; Ostardo E; Signorello D; Pastorello M; Caleffi G; Molon A; Artibani W
    Urologia; 2012; 79(2):90-6. PubMed ID: 22610844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.